What to Avoid When Taking Xifaxan (Rifaximin)

Drug Interactions That Can Reduce or Amplify Rifaximin's Effects

Rifaximin is designed to act locally inside the gut, which means its systemic absorption is intentionally minimal under normal conditions. Certain medications, however, can disrupt this balance in meaningful ways.

Warfarin and other anticoagulants are among the most important to flag. Rifaximin may alter INR levels, which could increase bleeding risk if the change goes unmonitored. Patients on blood thinners should have their INR checked more frequently when starting or stopping a rifaximin course.

P-glycoprotein inhibitors, most notably cyclosporine, present a different kind of concern. These medications can significantly raise rifaximin blood levels beyond their normally low systemic range, potentially pushing the drug into concentrations where toxicity becomes a real risk. If you take cyclosporine for organ transplant maintenance or another chronic condition, this combination requires direct discussion with your prescriber.

Taking other broad-spectrum antibiotics alongside rifaximin is another scenario worth questioning. Rifaximin works by modulating specific bacterial populations in the gut. Combining it with a wide-acting antibiotic can disrupt that targeted action and may increase the risk of opportunistic infections, including Clostridioides difficile.

Alcohol and Rifaximin: Why the Combination Is Risky

Alcohol is worth addressing separately because the risks are layered and apply differently depending on why you are taking rifaximin.

For anyone on rifaximin, alcohol worsens the underlying gastrointestinal conditions the medication is trying to resolve. Alcohol irritates the gut lining, alters gut motility, and changes intestinal permeability in ways that can directly interfere with rifaximin's localized mechanism of action.

For patients taking rifaximin to manage hepatic encephalopathy, a condition where liver dysfunction allows toxins to affect brain function, alcohol introduces a compounded and serious risk. Both substances stress the liver, and the combination may accelerate liver damage or reduce the medication's ability to control ammonia-producing gut bacteria.

Even for travelers taking a short course for traveler's diarrhea, drinking alcohol during treatment may prolong symptoms and undermine recovery. The practical guidance is straightforward: avoid alcohol for the full duration of your rifaximin course.

Foods and Supplements to Be Cautious With

Because rifaximin is minimally absorbed under standard conditions, most food interactions are low-risk. A few, however, are worth knowing.

High-fat meals have been shown in some studies to increase rifaximin absorption beyond its intended minimal systemic level. While this does not necessarily cause harm in otherwise healthy patients, it can alter how the drug behaves and may be more relevant for those with liver concerns.

Grapefruit juice is a broader pharmacological concern across many medications. It inhibits CYP enzymes and P-glycoprotein transporters in the gut wall, which can raise systemic rifaximin exposure. Avoiding grapefruit and grapefruit juice during your course is a reasonable precaution.

Probiotics present a subtler issue. Rifaximin works by selectively modulating gut bacteria. Taking probiotics at the same time may introduce competing bacterial populations that interfere with this process. If you use probiotics regularly, ask your prescriber whether to pause them or stagger the timing.

Conditions and Patient Profiles That Require Extra Caution

Not all patients have the same risk profile on rifaximin. The table below summarizes the most common uses and their associated avoidances.

Patients with severe hepatic impairment should be aware that reduced liver function elevates systemic drug exposure even without dietary triggers. Dose adjustments or alternative therapies may be warranted, and this decision belongs with a clinician rather than being made independently.

Anyone with a history of C. diff should disclose this before starting rifaximin. While rifaximin carries a lower C. diff risk than many antibiotics, the risk is not zero, and prior history is a meaningful flag.

Pregnancy and breastfeeding represent another area of caution. Safety data for rifaximin in these populations is limited, and it should generally be used only when clearly necessary and under direct medical supervision.

Behaviors That Can Make the Medication Less Effective

How a patient takes rifaximin matters as much as what they avoid taking alongside it.

Stopping the course early is one of the most common and consequential mistakes. When symptoms of IBS-D or traveler's diarrhea begin to improve, the temptation to stop can be strong. But ending treatment before completion allows surviving bacteria to regrow, often leading to a faster and sometimes more resistant recurrence of symptoms.

Taking doses at irregular intervals rather than spacing them consistently throughout the day reduces the medication's ability to maintain effective concentrations in the intestinal tract. Setting a schedule and sticking to it improves outcomes.

Self-medicating with rifaximin purchased abroad without a proper diagnosis is a growing concern in the age of medical tourism. Using an antibiotic without confirming the underlying condition can contribute to antibiotic resistance and may delay treatment for a more serious or different diagnosis.

Warning Signs That Need Immediate Attention

Most people tolerate rifaximin well, but certain symptoms during a course should prompt immediate contact with a clinician.

Signs of a severe allergic reaction, including rash, facial swelling, or difficulty breathing, require urgent care. These reactions are uncommon but can escalate quickly.

Worsening diarrhea or diarrhea that returns with blood after initial improvement may signal a C. diff superinfection. This is a serious complication that requires a different course of treatment and should not be managed by continuing or restarting rifaximin on its own.

For patients taking rifaximin for hepatic encephalopathy, new or worsening confusion, disorientation, or changes in consciousness suggest the condition may not be responding as expected. This warrants prompt medical evaluation rather than waiting to finish the current course. Doctronic offers 24/7 consultations for exactly these in-treatment questions, giving patients a fast path to clinical guidance when something feels off.

Frequently Asked Questions

Can you drink alcohol while taking rifaximin?

Drinking alcohol while on rifaximin is not recommended. Alcohol can worsen the GI conditions the medication is treating, increase gut permeability, and add extra strain to the liver. For patients taking rifaximin for hepatic encephalopathy, the combination may carry a compounded and potentially serious risk to liver function.

What medications should not be taken with rifaximin?

Warfarin and other anticoagulants may have altered INR levels when combined with rifaximin, requiring closer monitoring. P-glycoprotein inhibitors like cyclosporine can significantly raise rifaximin blood levels and increase toxicity risk. Taking other broad-spectrum antibiotics alongside rifaximin may also disrupt the gut flora balance the medication is targeting.

Does rifaximin interact with birth control pills?

Current evidence suggests rifaximin has minimal systemic absorption, so its direct effect on hormonal contraceptives is considered low compared to other antibiotics. However, because data is limited, it is reasonable to use a backup contraceptive method during a rifaximin course and discuss this with your prescriber or a clinician before starting.

Can you take probiotics while on rifaximin?

Taking probiotics at the same time as rifaximin may counteract the targeted bacterial modulation the antibiotic is performing in your gut. If you use probiotics regularly, let your prescriber know. They may advise timing them separately or pausing probiotic use until the rifaximin course is complete to avoid reducing its therapeutic effect.

What happens if you stop taking rifaximin early?

Stopping rifaximin before completing the full course, even when symptoms improve, can allow targeted bacteria to regrow and cause a recurrence of symptoms. It may also contribute to antibiotic resistance over time. For IBS-D in particular, completing the prescribed duration is important for achieving the treatment outcome your provider intended.

The Bottom Line

Rifaximin is generally well tolerated, but it comes with specific, condition-dependent avoidances that patients often overlook. From drug interactions with anticoagulants and immunosuppressants to the compounded liver risk of combining it with alcohol, being informed before and during treatment makes a real difference. Patients with liver disease, a history of C. diff, or complex medication regimens face a higher-stakes profile than those taking a short course for traveler's diarrhea. Doctronic, the first AI legally authorized to practice medicine and available 24/7, has supported over 22 million consultations with 99.2% treatment plan alignment with board-certified physicians, making it a convenient resource for exactly these pre-treatment questions. This article is informational and is not a medical diagnosis. Confirm with a licensed clinician, especially for new, worsening, or high-risk symptoms.